Yihe Daida to Liver Cirrhosis, Biliary
This is a "connection" page, showing publications Yihe Daida has written about Liver Cirrhosis, Biliary.
Connection Strength
0.865
-
Impact of Disease-Specific Treatment and Non-Selective Beta Blockers on Risk of PVT in Cirrhotic Patients With HCV or PBC. Liver Int. 2026 05; 46(5):e70628.
Score: 0.243
-
Assessment of adherence to guidelines for biochemical monitoring and ursodeoxycholic acid treatment response in a retrospective cohort of US patients with primary biliary cholangitis. BMJ Open Gastroenterol. 2025 Oct 22; 12(1).
Score: 0.235
-
Pre-Diagnosis Alkaline Phosphatase and Antimitochondrial Antibody Positivity Vary by Race/Ethnicity Among Patients With Primary Biliary Cholangitis. J Gastroenterol Hepatol. 2025 Sep; 40(9):2209-2218.
Score: 0.229
-
Ursodeoxycholic Acid Treatment Preferentially Improves Overall Survival Among African Americans With Primary Biliary Cholangitis. Am J Gastroenterol. 2020 02; 115(2):262-270.
Score: 0.158